ArticleJournal of gastrointestinal cancer2024

Efficacy and Safety of TACE Combined with a Tyrosine Kinase Inhibitor for the Treatment of TACE-Refractory Hepatocellular Carcinoma: A Retrospective Comparative Study.

Yu-Xing Chen et al.PubMed ↗Publisher ↗

No numbers read from the abstract.